News & Articles

The new assays are designed to enable turnaround times for next-generation sequencing results of less than 24 hours

Used to empower clinicians to quickly prescribe treatment regimens for multidrug-resistant TB, the test could help fill a critical gap that is jeopardizing global TB targets

Join us on Tuesday, September 1, to learn about why patients are admitted to an intensive care unit and what is available in terms of physiological support, monitoring, and treatments

Enables labs to quickly ramp up testing capacity and generate results faster

Learn about the potential of lateral flow assays in detecting symptomatic and asymptomatic COVID-19 infections

Dr. Jeremy Hirota takes us through the technology behind his translational research program for respiratory health

Nirsevimab is the first potential passive immunisation for infants to demonstrate sustained protection across the entire RSV season with a single dose

In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of disease severity, including Types 1, 2, and 3 SMA

This collaboration will allow Tecan to expand its presence for these product lines and reach a wider customer base across the academic and biotech communities

The high-throughput system enables laboratories to double or even triple their testing capacity

The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings

Crosslinking mass spectrometry (XL-MS) can leverage the PhoX Crosslinker and TIMS/PASEF methods with the large-scale use of accurate collision cross sections

The new reagent kits aim to make whole genome sequencing more accessible and affordable for labs of all sizes

This powerful new solution aims to provide more accurate COVID-19 antibody detection

Join us on Tuesday, August 11, to learn about a novel serological platform used for COVID-19 testing

Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing

Avacta appoints BBI Solutions as manufacturing partner for the rapid SARS-CoV-2 antigen test being developed with Cytiva

Trial supports Abbott's focus on being the best partner for electrophysiologists treating people living with atrial fibrillation

Vanderbilt researchers use high-throughput data collection, analysis, and visualization to help understand synergy in therapeutic antibody cocktails

Join us on Wednesday, August 26, to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours

BLENREP is the fifth major medicine approval for GSK in 2020

Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes